197 related articles for article (PubMed ID: 32361681)
1. MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses.
Chatterjee A; Kosmacek EA; Shrishrimal S; McDonald JT; Oberley-Deegan RE
Redox Biol; 2020 Jul; 34():101542. PubMed ID: 32361681
[TBL] [Abstract][Full Text] [Related]
2. MnTE-2-PyP protects fibroblast mitochondria from hyperglycemia and radiation exposure.
Chatterjee A; Sakallioglu IT; Murthy D; Kosmacek EA; Singh PK; McDonald JT; Powers R; Oberley-Deegan RE
Redox Biol; 2022 Jun; 52():102301. PubMed ID: 35358851
[TBL] [Abstract][Full Text] [Related]
3. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity.
Shrishrimal S; Chatterjee A; Kosmacek EA; Davis PJ; McDonald JT; Oberley-Deegan RE
Free Radic Biol Med; 2020 May; 152():255-270. PubMed ID: 32222469
[TBL] [Abstract][Full Text] [Related]
4. MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.
Chatterjee A; Kosmacek EA; Oberley-Deegan RE
Radiat Res; 2017 Mar; 187(3):367-381. PubMed ID: 28225655
[TBL] [Abstract][Full Text] [Related]
5. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
6. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation.
Makinde AY; Luo-Owen X; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS
Anticancer Res; 2009 Jan; 29(1):107-18. PubMed ID: 19331139
[TBL] [Abstract][Full Text] [Related]
7. The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation.
Oberley-Deegan RE; Steffan JJ; Rove KO; Pate KM; Weaver MW; Spasojevic I; Frederick B; Raben D; Meacham RB; Crapo JD; Koul HK
PLoS One; 2012; 7(9):e44178. PubMed ID: 22984473
[TBL] [Abstract][Full Text] [Related]
8. Manganese porphyrin, MnTE-2-PyP5+, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells.
Jaramillo MC; Briehl MM; Crapo JD; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2012 Apr; 52(8):1272-84. PubMed ID: 22330065
[TBL] [Abstract][Full Text] [Related]
9. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.
Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME
Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417
[TBL] [Abstract][Full Text] [Related]
10. The SOD Mimic, MnTE-2-PyP, Protects from Chronic Fibrosis and Inflammation in Irradiated Normal Pelvic Tissues.
Shrishrimal S; Kosmacek EA; Chatterjee A; Tyson MJ; Oberley-Deegan RE
Antioxidants (Basel); 2017 Nov; 6(4):. PubMed ID: 29113120
[TBL] [Abstract][Full Text] [Related]
11. MnTE-2-PyP reduces prostate cancer growth and metastasis by suppressing p300 activity and p300/HIF-1/CREB binding to the promoter region of the PAI-1 gene.
Tong Q; Weaver MR; Kosmacek EA; O'Connor BP; Harmacek L; Venkataraman S; Oberley-Deegan RE
Free Radic Biol Med; 2016 May; 94():185-94. PubMed ID: 26944191
[TBL] [Abstract][Full Text] [Related]
12. MnTE-2-PyP modulates thiol oxidation in a hydrogen peroxide-mediated manner in a human prostate cancer cell.
Tong Q; Zhu Y; Galaske JW; Kosmacek EA; Chatterjee A; Dickinson BC; Oberley-Deegan RE
Free Radic Biol Med; 2016 Dec; 101():32-43. PubMed ID: 27671770
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
[TBL] [Abstract][Full Text] [Related]
14. Manganese-porphyrin reactions with lipids and lipoproteins.
Bloodsworth A; O'Donnell VB; Batinic-Haberle I; Chumley PH; Hurt JB; Day BJ; Crow JP; Freeman BA
Free Radic Biol Med; 2000 Apr; 28(7):1017-29. PubMed ID: 10832063
[TBL] [Abstract][Full Text] [Related]
15. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
[TBL] [Abstract][Full Text] [Related]
16. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.
Mackensen GB; Patel M; Sheng H; Calvi CL; Batinic-Haberle I; Day BJ; Liang LP; Fridovich I; Crapo JD; Pearlstein RD; Warner DS
J Neurosci; 2001 Jul; 21(13):4582-92. PubMed ID: 11425886
[TBL] [Abstract][Full Text] [Related]
18. Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.
Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Rebouças JS; Batinic-Haberle I; Vujaskovic Z
Free Radic Biol Med; 2010 Apr; 48(8):1034-43. PubMed ID: 20096348
[TBL] [Abstract][Full Text] [Related]
19. A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin.
Gad SC; Sullivan DW; Crapo JD; Spainhour CB
Int J Toxicol; 2013 Jul; 32(4):274-87. PubMed ID: 23704100
[TBL] [Abstract][Full Text] [Related]
20. A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.
Moeller BJ; Batinic-Haberle I; Spasojevic I; Rabbani ZN; Anscher MS; Vujaskovic Z; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):545-52. PubMed ID: 16168847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
